Pricing Log in Create free account

Inogen, Inc (INGN) vs TriSalus Life Sciences, Inc. (TLSI)

Inogen, Inc and TriSalus Life Sciences, Inc. are both Medical Devices companies. TriSalus Life Sciences, Inc. is the larger, with a market value of $217.4M against $179.7M — 1.2× the size. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 3.15%. Inogen, Inc has the higher net margin (−6.94% vs −130.2%) and the lower return on invested capital (−28.4% vs 0.00%). Across the 17 metrics below, Inogen, Inc leads on 11 and TriSalus Life Sciences, Inc. on 6.

Valuation

Metric INGN TLSI Medical Devices median
P/E n/m n/m 25.58
P/S 0.52 4.60 2.54
P/B 1.04 31.69 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 0.21 4.32 2.72
Earnings yield (13.33%) (36.52%) (12.82%)
Free cash flow yield (4.30%) (11.55%) (8.18%)

Profitability

Metric INGN TLSI Medical Devices median
Gross margin 44.51% 85.79% 57.76%
Operating margin (8.71%) (67.68%) (15.07%)
Net margin (6.94%) (130.17%) (14.45%)
Free cash flow margin (2.22%) (51.56%) (3.88%)
Return on equity (13.14%) 911.60% (10.35%)
Return on assets (8.23%) (113.09%) (17.26%)
Return on invested capital (28.35%) 0.00% (5.27%)

Growth

Metric INGN TLSI Medical Devices median
Revenue growth (TTM) 3.15% 25.25% 10.41%
EPS growth (last fiscal year) 43.42% (40.46%) 28.17%
Revenue growth, 5-year CAGR 2.48% — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INGN TLSI Medical Devices median
Debt to equity 0.00 5.05 0.04
Current ratio 2.74 5.35 2.74
Net debt to EBITDA 12.66 (0.50) 0.54

Dividend

Metric INGN TLSI Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric INGN TLSI Medical Devices median
Market cap 179.67m 217.36m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack